Atlas Trials

Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells

Clinical trial NCT07732712 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07732712
Sponsor
The Affiliated People's Hospital of Ningbo University
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2026-08-01
Primary completion
2028-08-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.